| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/28/2007 | US7262040 Incorporating into a protein an unnatural amino acid that has a saccharide moiety using an orthogonal tRNA/orthogonal aminoacyl-tRNA synthetase (O-tRNA/O-RS) pair, and contacting the saccharide moiety with a recombinant glycosyltransferase and a sugar donor to transfer a sugar to the saccharide moiety |
| 08/28/2007 | US7262039 Having an alpha 1,3-fucosyltransferase activity |
| 08/28/2007 | US7262028 Recombinant production of mixtures of antibodies |
| 08/28/2007 | US7262027 Polypeptide and DNA immunization against Coccidioides spp. infections |
| 08/28/2007 | US7262026 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 08/28/2007 | US7262025 Expression vector/plasmid comprising a cytomegalovirus (CMV) enhancer and a myeloproliferative sarcoma viral regulatory sequence for use as gene transfer and expression agent |
| 08/28/2007 | US7262024 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections |
| 08/28/2007 | US7262015 As a target for drug development against Chagas' disease |
| 08/28/2007 | US7262014 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 08/28/2007 | US7262012 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 08/28/2007 | US7261901 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 08/28/2007 | US7261899 Method of producing thy A-strains of Vibrio cholerae, such strains and their use |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | US7261893 Neutralizing antibodies against GDF-8 and uses therefor |
| 08/28/2007 | US7261891 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | CA2203373C Process for improved recombinant production of disulphide bond-containing polypeptides via a protein disulfide isomerase |
| 08/28/2007 | CA2188165C Methods for proliferating and differentiating b cells, and uses thereof |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/28/2007 | CA2124460C Production of anti-self antibodies from segment repertoires and displayed on phage |
| 08/28/2007 | CA2123355C Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci |
| 08/28/2007 | CA1341538C Dna encoding ige receptor alpha-subunit or fragment thereof |
| 08/23/2007 | WO2007095243A2 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/23/2007 | WO2007094760A1 Vectors and methods for identifying proteins amenable to crystallization |
| 08/23/2007 | WO2007094620A1 Preparation of cell extract and its application for cell-free protein systhesis |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094342A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007094269A1 Method for efficient purification of bionanocapsule |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007053524A3 Horse: human chimeric antibodies |
| 08/23/2007 | WO2007001677A9 Compositions and methods for immunomodulation in an organism |
| 08/23/2007 | WO2005030932A3 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 08/23/2007 | WO2004018698A3 Lectin compositions and methods for modulating an immune response to an antigen |
| 08/23/2007 | WO2004017926A3 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | US20070199082 Method of diagnosis of obesity |
| 08/23/2007 | US20070199081 Variants of the gamma chain of vertebrate AMP-activated kinase (AMPK), as well as nucleic acid sequences encoding the variants and use thereof for the diagnosis or treatment of dysfunction of energy metabolisms |
| 08/23/2007 | US20070199080 Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders |
| 08/23/2007 | US20070197438 cathepsin mediated diseases; proteinuria, cancer, and cognitive diseases; podocyte cell gene transfer |
| 08/23/2007 | US20070197431 Novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070197426 Lactoferrin polypeptide, process for producing the same and inflammation inducing substance |
| 08/23/2007 | US20070196901 Kahalalide-producing bacteria |
| 08/23/2007 | US20070196900 Method for the manufacture of lantibiotics |
| 08/23/2007 | US20070196899 Mutant protein having diaphorase activity |
| 08/23/2007 | US20070196898 Subtilases |
| 08/23/2007 | US20070196897 Polynucleotides encoding a novel human g-protein coupled receptor splice variant, hgprbmy29sv2 |
| 08/23/2007 | US20070196896 Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens |
| 08/23/2007 | US20070196895 alternative media free from animal sources; Chinese hamster ovary (CHO) cells; Asparagine, Sodium Chloride, Selenite, Wheat hydrolysate and Insulin |
| 08/23/2007 | US20070196883 Enzyme |
| 08/23/2007 | US20070196879 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 08/23/2007 | US20070196867 GPCR expressing cell lines and antibodies |
| 08/23/2007 | US20070196838 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 08/23/2007 | US20070196449 MUTANTS OF ASPERGILLUS NIGER PhyA PHYTASE AND ASPERGILLUS FUMIGATUS PHYTASE |
| 08/23/2007 | US20070196448 Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 08/23/2007 | US20070196429 Proteins of natural origin and materials made therefrom |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196382 Saccharomyces cerevisiae strains for hyper-producing glutathione and gamma-glutamylcysteine and processes of use |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196376 Binding proteins specific for insulin-like growth factors and uses thereof |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196365 Immunoglobulin heavy chain variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/23/2007 | US20070196363 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/23/2007 | US20070196345 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 08/23/2007 | US20070196339 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/23/2007 | US20070196333 Composition comprising mixtures of IFN-alpha subtypes |
| 08/23/2007 | US20070196276 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 08/23/2007 | CA2642539A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 08/23/2007 | CA2642138A1 Production of foreign nucleic acids and polypeptides in plant systems |
| 08/23/2007 | CA2642054A1 Influenza antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2641264A1 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/23/2007 | CA2638915A1 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2638794A1 Functional antibodies |
| 08/23/2007 | CA2636797A1 Non-natural amino acid polypeptides having modulated immunogenicity |
| 08/22/2007 | EP1820862A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820858A1 Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof |
| 08/22/2007 | EP1820855A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 08/22/2007 | EP1819830A2 Methods for antibody engineering |
| 08/22/2007 | EP1819829A1 Recombinant method for making multimeric proteins |
| 08/22/2007 | EP1819825A2 Thermostable omega-transaminases |
| 08/22/2007 | EP1819816A2 Methods for the production and secretion of modified peptides |
| 08/22/2007 | EP1819731A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 08/22/2007 | EP1819725A1 Production of proteins |
| 08/22/2007 | EP1660654A4 Expression vector |
| 08/22/2007 | EP1641422A4 Interleukin-21 analogs |
| 08/22/2007 | EP1534848B1 Method for extracting proteins |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1487868B1 Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 08/22/2007 | EP1402024B1 Templated molecules and methods for using such molecules |
| 08/22/2007 | EP1250439B1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/22/2007 | EP1244799B1 Methods and materials relating to gene expression |